-
Live attenuated vaccines
Contain a weakened form of a living pathogen that can replicate to a limited extent. They often produce strong, long-lasting immunity.
Examples: MMR, varicella, rotavirus, yellow fever, BCG, and intranasal live influenza vaccine. They are generally avoided in people with severe immunocompromise and during pregnancy.
CDC guidance
-
Inactivated (killed) vaccines
Contain pathogens that have been killed, so they cannot replicate or cause infection. Booster doses are often needed.
Examples: inactivated polio vaccine, hepatitis A vaccine, rabies vaccine, and many injectable influenza vaccines.
-
Toxoid vaccines
Contain an inactivated bacterial toxin rather than the organism itself.
Examples: tetanus and diphtheria vaccines.
-
Subunit vaccines
Contain selected antigenic parts of a pathogen, rather than the whole organism.
Examples: hepatitis B vaccine, acellular pertussis vaccine, HPV vaccine, and recombinant influenza vaccine.
-
Polysaccharide vaccines
Contain purified capsular polysaccharides from bacteria. They may generate a weaker immune response in young children.
Example: pneumococcal polysaccharide vaccine (PPSV23).
-
Conjugate vaccines
Bacterial polysaccharide is linked to a protein carrier, producing better immune memory, especially in infants and young children.
Examples: Hib vaccine, pneumococcal conjugate vaccines, and meningococcal conjugate vaccines.
-
mRNA vaccines
Deliver messenger RNA that instructs cells to make a harmless antigen, which triggers immune recognition. The mRNA does not enter or alter DNA.
Examples: Pfizer-BioNTech and Moderna COVID-19 vaccines.
CDC explanation
-
Viral-vector vaccines
Use a modified, harmless virus to deliver genetic instructions for an antigen.
Examples: some Ebola and COVID-19 vaccines.
-
Virus-like particle vaccines
Contain noninfectious structures that mimic the outer shell of a virus but have no viral genetic material.
Example: HPV vaccine.
-
Nucleic-acid and newer platform vaccines
These include DNA vaccines and some vector or nanoparticle-based platforms. Many are used in limited settings or are still being developed.